Cellectis to Hold Fourth Quarter 2021 Earnings Call on Friday March 4, 2022 at 8:00AM EST
Published on February 24, 2022 in New York, NY
February 24, 2022 – New York - Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that it will report its financial results for the fourth quarter and year-end 2021 ending December 31, 2021, on Thursday, March 3, 2022, after the close of the US market.
The announcement will be followed by a conference call and live audio webcast on Friday, March 4, 2022, at 8:00 AM EDT / 2:00 PM CET, prior to the open of the US market. The call will include the Company’s fourth quarter results, year-end results, and an update on business activities. Details for the call are as follows:
Live (US/Canada): + 1(877) 451-6152
Live (international): + 1(201) 389-0879
Conference ID: 13727032
The webcast audio will be made available for one year on the Company’s website here.